Discussion about this post

User's avatar
Tom Neltner's avatar

I have watched FDA scientists for 15 years as they systematically dismiss epidemiology studies as unreliable. Only when the evidence is overwhelming (and adopted by other agencies) do they adopt it. It was not until 2018 that they adopted the findings on lead. They do the same for studies conducted by academics because they prefer industry studies conducted pursuant their "Redbook" standards. Those standards were written in the 1980s and do not reflect the subtle but critical health endpoints related to neurology, immunology, and endocrinology. I am concerned that folks are using the term "gold standard science" to refer to those industry studies and enable them to dismiss epidemiology and academic studies.

Expand full comment
PFPC Canada's avatar

Your post on the systemic delays that have allowed these chemicals to harm entire populations is much appreciated. Your description of how regulatory frameworks demand “definitive proof” before acting - while contamination continues - was both accurate and important.

In the case of fluoride - both inorganic forms used in mass fluoridation programs and organic forms such as PFAS - the effects on thyroid hormone metabolism have been well documented since the 1930s and 1940s. Yet, these effects were denied for decades and continue to be denied by agencies meant to protect public health (WHO, EFSA, CDC, etc.). This continuing delay has undoubtedly caused substantial harm worldwide.

But there is another, often overlooked contributor to delay: scientific negligence. And in this case, it comes from within the very field seeking to raise the alarm.

In 2016, you co-authored a study showing that PFAS effects on thyroid hormones varied according to TPOAb and iodine status (Webster et al., 2016). In that paper, you and your co-authors explicitly wrote:

"Future research on PFASs and other thyroid-disrupting chemicals should consider effect modification by thyroid system stressors, including TPOAb, iodine deficiency, and pregnancy, among others."

Unfortunately, in that paper iodine status was only dichotomized as "deficient" versus "normal," with "normal" defined as >100 µg/L. This is certainly not adequate considering the well-established U-curve effects of iodine on health. Since then, numerous studies have confirmed that PFAS toxicity on thyroid hormones is modified by TPOAb status (thyroid autoimmunity), especially during pregnancy (e.g. Korevaar, 2018; Wang et al., 2023; Itoh et al., 2019).

Yet, when you later examined PFAS exposure in the MIREC cohort (Goodman et al., 2023), neither iodine status nor TPOAb was considered at all - despite the fact that nearly 90% of the women were taking iodine-containing supplements and had demonstrable elevated iodine levels and higher TPOAb titers - the classic result of more-than-adequate iodine intake. Why were iodine and TPOAb not considered in this study?

In all the papers published on the cohort, iodine has never been addressed properly. A persistent and fundamental misconception remains that risk exists only at the low end of iodine intake, while the dangers of more-than-adequate intake are ignored. Recent papers on iodine status in the MIREC cohort (Berghuis et al., 2025; Krzeczkowski et al., 2023) exemplify this failure. The studies relied on inappropriate reference ranges and methodology, and largely ignored the U-shaped relationship between iodine and thyroid outcomes.

This is not a minor oversight. It directly biases risk estimates and obscures true PFAS toxicity. More-than-adequate iodine intake, at the levels seen in MIREC, has been shown to increase the toxicity of lead, cadmium, and other pollutants (e.g., Mergetaki et al., 2021) - in addition to causing significant harm on its own. While little can be done now about the historic delay in PFAS regulation and the widespread contamination, the public - and especially pregnant women and young children - could at least be alerted to monitor iodine intake, as this strongly influences how these toxic substances affect thyroid hormone metabolism. Failure to do so risks damage that can be passed on to future generations.

Negligence and scientific ignorance can delay action just as effectively as industry lobbying, and often longer, because they masquerade as science. By ignoring well-known effect modifiers and failing to properly assess iodine effects, your group’s work risks providing false reassurance and faulty conclusions, which in turn lead to continued exposure and preventable harm.

If the toxicity of lead, PFAS, cadmium, fluoride, and similar substances is misrepresented because it is studied without adequately accounting for high iodine intake, then the public is not protected. They are being misled.

The system’s failures are not only political - they are also scientific. And acknowledging that is essential if we are to break the cycle of delay.

References

Berghuis SA, Hall M, Krzeczkowski JE, Goodman CV, Chevrier J, Ayotte P, Lanphear B, Till C - "Urinary Iodine Concentration and Thyroid Hormone Metabolism in Pregnant Women and Neurodevelopment in Their Children: A Longitudinal Canadian Birth Cohort" Nutrients 17(5):830 (2025) d

https://www.mdpi.com/2072-6643/17/5/830

Goodman CV, Till C, Green R, El-Sabbagh J, Arbuckle TE, Hornung R, Lanphear B, Seguin JR, Booij L, Fisher M, Muckle G, Bouchard MF, Ashley-Martin J - "Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: The MIREC cohort" Neurotoxicol Teratol 98:107181 (2023)

https://www.sciencedirect.com/science/article/pii/S0892036223000314

Itoh S, Araki A, Miyashita C, Yamazaki K, Goudarzi H, Minatoya M, Ait Bamai Y, Kobayashi S, Okada E, Kashino I, Yuasa M, Baba T, Kishi R - "Association between perfluoroalkyl substance exposure and thyroid hormone/thyroid antibody levels in maternal and cord blood: The Hokkaido Study" Environ Int. 133(Pt A):105139 (2019)

https://www.sciencedirect.com/science/article/pii/S0160412019301199

Korevaar TIM - "Exposure to Per- and Polyfluoroalkyl Substances Is Associated with Lower Thyroid Hormone Availability during Pregnancy" Clin Thyroidol 30(4):190-192 (2018)

https://www.liebertpub.com/doi/abs/10.1089/ct.2018%3B30.190-192

Krzeczkowski JE, Hall M, McGuckin T, Lanphear B, Bertinato J, Ayotte P, Chevrier J, Goodman C, Green R, Till C - "Iodine status in a large Canadian pregnancy cohort" Am J Obstet Gynecol MFM 5(1):100784 (2023)

https://linkinghub.elsevier.com/retrieve/pii/S2589-9333%2822%2900214-2

Margetaki K, Vafeiadi M, Kampouri M, Roumeliotaki T, Karakosta P, Daraki V, Kogevinas M, Hu H, Kippler M, Chatzi L - "Associations of exposure to cadmium, antimony, lead and their mixture with gestational thyroid homeostasis" Environ Pollut 289:117905 (2021)

https://pmc.ncbi.nlm.nih.gov/articles/PMC11808336/

Wang X, Yang L, Wang Z, Feng X, Ji H, Liang H, Song X, Miao M - "Association between perfluoroalkyl and polyfluoroalkyl substances and maternal thyroid-related hormones in pregnant women" J Environ Occup Med 40(12):661-666 (2023)

https://www.jeom.org/cn/article/doi/10.11836/JEOM22314

https://pesquisa.bvsalud.org/gim/resource/pt/wpr-976511

Webster GM, Rauch SA, Marie NS, Mattman A, Lanphear BP, Venners SA - "Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008)" Environ Health Perspect 124(7):935-42 (2016)

https://ehp.niehs.nih.gov/doi/10.1289/ehp.1409589

Expand full comment
18 more comments...

No posts

Ready for more?